Form 8-K - Current report:
SEC Accession No. 0001356576-25-000042
Filing Date
2025-06-17
Accepted
2025-06-17 16:40:35
Documents
12
Period of Report
2025-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K supn-20250616.htm   iXBRL 8-K 37961
  Complete submission text file 0001356576-25-000042.txt   153045

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20250616.xsd EX-101.SCH 1785
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20250616_lab.xml EX-101.LAB 21615
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20250616_pre.xml EX-101.PRE 12510
14 EXTRACTED XBRL INSTANCE DOCUMENT supn-20250616_htm.xml XML 2727
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 251053883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)